Apollo Hospitals reports Q3′ FY21 earnings

Read Article

For the Q3 ‘FY21 standalone revenues degrew by six per cent to Rs.23,670 mn compared to Rs.25,295 mn in Q3’ FY20, aided by growth in Healthcare services degrowth of four per cent YoY and SAP
business degrowth of nine per cent.

EBITDA (Pre Ind AS 116) was at Rs 3,012 mn in Q3FY21 as against Rs 3,195 mn in Q3FY20 a YoY degrowth of six per cent. PAT grew by 12 per cent to Rs.1,062 mn in Q3FY21.

Pharmacy business degrew by nine per cent to Rs 11,263 mn as against Rs 12,326 mn in Q3FY20.

Healthcare services degrew four per cent YoY, mature hospitals degrew by eight per cent YoY and new hospitals grew seven per cent.

Dr Prathap C Reddy, Chairman, Apollo Hospitals Group said, “The first three quarters of the year have been a period of resilience and recovery for Apollo Hospitals. It is a testament to the strong foundation
laid over our 37 years of experience in healthcare that we have been able to emerge stronger than ever before despite the challenges due to the COVID pandemic.

The third quarter of the year saw robust
growth as we increased focus on non-Covid patients, especially NCDs, which pose a substantial risk factor to the health of the people. This was also a result of our successful efforts in educating our
patients on the risks of ignoring symptoms and addressing their fears of visiting a hospital during the pandemic.

We were very clear that we would continue to leverage not just the latest medical technologies at our disposal, but also invest in new developments harnessing AI, ML and big data to benefit our patients.

This was seen in our multiple collaborations during the quarter and I would like to highlight some of these.

We collaborated with Tata Medical and Diagnostics to introduce TataMD CHECK diagnostic test for COVID-19 in the country. This is the world’s first CRISPR Cas-9-based diagnostic test and gives faster and accurate results as compared to the conventional tests.

We continued to be the torchbearer in adoption of digital technology as the first hospital group in South Asia to use AI for comprehensive stroke management and joined hands with Medtronic – a world leader in neuro-interventional devices to transform stroke treatment in the country.

We launched the first-of-a-kind knee replacement programme in Bengaluru offering specialised partial and total knee replacement care with the use of advanced robotic technology, the NAVIO surgical system.

This will help address the rising health concern of osteoarthritis, a painful crippling condition. Our hospital in Indore became the first day care centre in the country for both knee and hip replacement that allows the patient to be discharged on the same day.

We are committed to wellness, and have continued to lay emphasis on preventive health checks as the backbone of early detection and cure. We have completed over 22 million health checks so far, and have
also completed over 1,00,000 health checks for members and dependents in the Apollo Family. Our flagship programme ProHealth offers a comprehensive and holistic solution to good health, and we will take the programme to a large part of our society through corporates, residential societies, civil society groups and retail outreach.

We stand by the Government wholeheartedly in its mission to ensure that every Indian is vaccinated against COVID-19. With 27 vaccination centres operational already, we are poised to leverage the strength of our robust pan India network of 19 medicine-supply hubs with cold chain facilities and our 70 hospitals, 400+ clinics, 500 corporate health centers, 4000 pharmacies alongside the Omni channel digital platform Apollo 24|7 to ensure safe, comprehensive delivery and efficient and fast administration of vaccines with the highest safety standards. This will enable us to work with the Government to ensure that a large number of people get the vaccine, quickly and safely through the
different phases of the mammoth vaccination programme.

Our successful QIP fund raise is an acknowledgement of the faith of investors in our strong business fundamentals and strategy, and we shall continue to work to deliver growth and leverage opportunities
in the healthcare industry to maintain our leadership position.

In addition, three of the top five hospitals and five of the top 20 in the National rankings are part of the Apollo Hospitals group. Even at the regional level, the top three in the South, the leader in the North, two among the top three in the East and one among the top 15 in the West belong to the Apollo Hospital group.”